chr10-52264069-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_006258.4(PRKG1):​c.1174-7281T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0387 in 152,200 control chromosomes in the GnomAD database, including 493 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.039 ( 493 hom., cov: 33)

Consequence

PRKG1
NM_006258.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.24

Publications

2 publications found
Variant links:
Genes affected
PRKG1 (HGNC:9414): (protein kinase cGMP-dependent 1) Mammals have three different isoforms of cyclic GMP-dependent protein kinase (Ialpha, Ibeta, and II). These PRKG isoforms act as key mediators of the nitric oxide/cGMP signaling pathway and are important components of many signal transduction processes in diverse cell types. This PRKG1 gene on human chromosome 10 encodes the soluble Ialpha and Ibeta isoforms of PRKG by alternative transcript splicing. A separate gene on human chromosome 4, PRKG2, encodes the membrane-bound PRKG isoform II. The PRKG1 proteins play a central role in regulating cardiovascular and neuronal functions in addition to relaxing smooth muscle tone, preventing platelet aggregation, and modulating cell growth. This gene is most strongly expressed in all types of smooth muscle, platelets, cerebellar Purkinje cells, hippocampal neurons, and the lateral amygdala. Isoforms Ialpha and Ibeta have identical cGMP-binding and catalytic domains but differ in their leucine/isoleucine zipper and autoinhibitory sequences and therefore differ in their dimerization substrates and kinase enzyme activity. [provided by RefSeq, Sep 2011]
PRKG1-AS1 (HGNC:45029): (PRKG1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.33 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006258.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKG1
NM_006258.4
MANE Select
c.1174-7281T>C
intron
N/ANP_006249.1Q13976-2
PRKG1
NM_001098512.3
c.1129-7281T>C
intron
N/ANP_001091982.1Q13976-1
PRKG1
NM_001374781.1
c.-36-7281T>C
intron
N/ANP_001361710.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKG1
ENST00000373980.11
TSL:1 MANE Select
c.1174-7281T>C
intron
N/AENSP00000363092.5Q13976-2
PRKG1-AS1
ENST00000426785.2
TSL:1
n.170-10629A>G
intron
N/A
PRKG1
ENST00000401604.8
TSL:5
c.1129-7281T>C
intron
N/AENSP00000384200.4Q13976-1

Frequencies

GnomAD3 genomes
AF:
0.0387
AC:
5881
AN:
152080
Hom.:
493
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0167
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.113
Gnomad ASJ
AF:
0.00547
Gnomad EAS
AF:
0.343
Gnomad SAS
AF:
0.103
Gnomad FIN
AF:
0.0479
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.00882
Gnomad OTH
AF:
0.0330
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0387
AC:
5891
AN:
152200
Hom.:
493
Cov.:
33
AF XY:
0.0442
AC XY:
3289
AN XY:
74402
show subpopulations
African (AFR)
AF:
0.0169
AC:
701
AN:
41562
American (AMR)
AF:
0.113
AC:
1722
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.00547
AC:
19
AN:
3472
East Asian (EAS)
AF:
0.343
AC:
1769
AN:
5154
South Asian (SAS)
AF:
0.103
AC:
499
AN:
4824
European-Finnish (FIN)
AF:
0.0479
AC:
509
AN:
10622
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.00882
AC:
600
AN:
67990
Other (OTH)
AF:
0.0313
AC:
66
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
245
490
736
981
1226
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0202
Hom.:
541
Bravo
AF:
0.0442
Asia WGS
AF:
0.213
AC:
740
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.24
DANN
Benign
0.37
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16913596; hg19: chr10-54023829; API